Timber Creek Capital Management’s Biogen BIIB Stock Holding History

Timber Creek Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4	Closed	-$1.14K	–	130
2023 Q2	$1.14K	Buy	+4	New	+$1.19K	﹤0.01%	131
2022 Q1	–	Sell	-7,150	Closed	-$1.72M	–	129
2021 Q4	$1.72M	Sell	7,150 -8,225	-53%	-$2.11M	0.51%	44
2021 Q3	$4.35M	Sell	15,375 -72	-0.5%	-$23.6K	1.38%	32
2021 Q2	$5.35M	Buy	15,447 +3,026	+24%	+$917K	1.73%	30
2021 Q1	$3.47M	Buy	12,421 +565	+5%	+$152K	1.34%	33
2020 Q4	$2.9M	Buy	11,856 +5,038	+74%	+$1.3M	1.29%	30
2020 Q3	$1.93M	Buy	+6,818	New	+$1.9M	1.06%	30

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Timber Creek Capital Management's BIIB Position: Q3 2023 in Review

Timber Creek Capital Management sold out of Biogen (BIIB) in Q3 2023, closing a stake of 4 shares — an estimated $1.14K sold.

Timber Creek Capital Management first reported a position in BIIB in Q3 2020 and held it in 7 quarters. The position peaked at $5.35M in Q2 2021. 966 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

Timber Creek Capital Management reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
Timber Creek Capital Management sold 4 Biogen shares in Q3 2023, an estimated $1.14K.
Timber Creek Capital Management first reported a position in Biogen in Q3 2020 and held it in 7 quarters.
Timber Creek Capital Management's Biogen position peaked at $5.35M in Q2 2021.
966 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Timber Creek Capital Management's 13F filing for Q3 2023, filed 18 Oct 2023.